Effects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd)

Bahlis, N. J., Richard, S., White, D. J., Grosicki, S., Chen, C., Delimpasi, S., Sutherland, H. J., Maslyak, Z., Sebag, M., Gavriatopoulou, M., Lentzsch, S., Chari, A., Simonova, M., Spicka, I., Kriachok, I., Dimopoulos, M. A., Pylypenko, H., Auner, H. W., Leleu, X., … Richardson, P. G. (2021). Effects of Cytogenetic Risk on Outcomes in Multiple Myeloma Treated with Selinexor, Bortezomib, and Dexamethasone (XVd). Blood, 138(Supplement 1), 1634–1634. https://doi.org/10.1182/blood-2021-146324
Authors:
Nizar J. Bahlis
Shambavi Richard
Darrell White
Sebastian Grosicki
Christine Chen
Sosana Delimpasi
Heather J. Sutherland
Zvenyslava Maslyak
Michaël Sébag
Maria Gavriatopoulou
Suzanne Lentzsch
Ajai Chari
Maryana Simonova
Ivan Špıčka
Iryna Kriachok
Meletios Α. Dimopoulos
Halyna Pylypenko
Holger W. Auner
Xavier Leleu
Ganna Usenko
Roman Hájek
Reuben Benjamin
Tuphan Kanti Dolai
Dinesh Kumar Sinha
Christopher P. Venner
Mamta Garg
Don A. Stevens
Hang Quach
Sundar Jagannath
Philippe Moreau
Moshe Levy
Ashraf Badros
Larry D. Anderson
Thierry Façon
María‐Victoria Mateos
Michèle Cavo
Andrew DeCastro
Yi Chai
Dane R. Van Domelen
Moran Mishal
Ohad S. Bentur
Jatin J. Shah
Sharon Shacham
Michael Kauffman
Paul G. Richardson
Affiliated Authors:
Suzanne Lentzsch
Columbia Affiliation:
Subjects:
Diagnosis and Treatment of Multiple Myeloma (OpenAlex Topic)
Molecular Pathogenesis of Myeloproliferative Disorders (OpenAlex Topic)
Targeted Protein Degradation in Biomedical Research (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2021-146324
DOI:
10.1182/blood-2021-146324
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: